A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Clinical Characteristics of the Chinese Patients With Lung Malignant Tumors Who Received Surgeries or Surgeries Plus Adjuvant Therapies
1 other identifier
observational
21,777
1 country
10
Brief Summary
The study was designed to evaluate effectiveness of the surgeries and adjuvant therapies after surgeries in the patients with lung malignant tumors
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2017
Shorter than P25 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 29, 2017
CompletedFirst Posted
Study publicly available on registry
February 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2018
CompletedMay 21, 2018
May 1, 2018
4 months
December 29, 2017
May 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Demographic characteristics of the patients with lung malignant tumors who received surgeries
Demographic characteristics of the patients with lung malignant tumors who received surgeries of thoracotomy, video-assistant thoracic surgery or robotic thoracic surgery as measured by: * Age * Gender * Payment types * Insurance types * Smoking history * Complications and symptoms of complications * Respiratory functions * Type of diagnoses
2014 - 2017
Secondary Outcomes (3)
Location of tumors and tumor sizes
2014 - 2017
Tumor clinical/pathological staging
2014 - 2017
Type of biomarkers
2014 - 2017
Other Outcomes (15)
Differences in overall survivals of the patients with surgeries
2014 - 2017
Impact factors of patient survival in patients with tumor size =<2 cm who received surgeries as measured by tumor clinical/pathological staging
2014 - 2017
Impact factors of patient survival in patients with tumor size =<2 cm who received surgeries as measured by location of tumors and tumor sizes
2014 - 2017
- +12 more other outcomes
Study Arms (1)
Surgeries and adjuvant therapies
Surgeries or surgeries plus adjuvant therapies
Interventions
Surgeries or surgeries plus adjuvant therapies
Eligibility Criteria
Patients with lung malignant tumors who were performed with surgeries
You may qualify if:
- Age \>= 18 years old;
- Pathologically diagnosed lung malignant tumors after surgeries;
- Patients with lung surgeries;
- Patients with complete medical health records and follow-up visit information (at least one follow-up visit);
You may not qualify if:
- Patients who were not performed with surgeries;
- Pathologically diagnosed patients with benign diseases after surgeries;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- West China Hospitallead
- LinkDoc Technology (Beijing) Co. Ltd.collaborator
Study Sites (10)
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
China PLA General Hospital
Beijing, Beijing Municipality, 100853, China
Henan cancer hospital
Zhengzhou, Henan, 450008, China
Tongji Hospital Affiliated to Huaxi Technology University
Wuhan, Hubei, 430030, China
Jiangsu cancer hospital
Nanjing, Jiangsu, 210009, China
Xi'an Tangdu Hospital
Xi'an, Shaanxi, 710000, China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, 200030, China
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, 300051, China
First Hospital Affiliated to Zhejiang University
Hangzhou, Zhejiang, 310003, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lunxun Liu, PhD
West China Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 29, 2017
First Posted
February 5, 2018
Study Start
December 1, 2017
Primary Completion
March 30, 2018
Study Completion
March 30, 2018
Last Updated
May 21, 2018
Record last verified: 2018-05